Efficacy of supplemental MCT oil on seizure reduction of adult drug-resistant epilepsy - a single-center open-label pilot study
We set out to determine whether adding medium chain triglyceride (MCT) oil as a dietary supplement to standard diet in adult subjects with intractable epilepsy in a U.S. neurology clinical practice was associated with a reduction in number of seizures. We secondarily aimed to determine whether subje...
Saved in:
Published in | Nutritional neuroscience Vol. 26; no. 6; pp. 535 - 539 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Taylor & Francis
03.06.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | We set out to determine whether adding medium chain triglyceride (MCT) oil as a dietary supplement to standard diet in adult subjects with intractable epilepsy in a U.S. neurology clinical practice was associated with a reduction in number of seizures. We secondarily aimed to determine whether subjects experienced any side effects and whether there was a presence of urinary ketones while using MCT oil as a dietary supplement.
Adult patients with intractable epilepsy were recruited at standard of care clinical visits with their epileptologist. Once enrolled, subjects were instructed to supplement their diet with MCT oil as tolerated twice daily for three months (including a 1-2 week titration period, followed by a 1-2 week tapering off window) while keeping a seizure diary to record total number of seizures, presence of urinary ketones, and any side effects.
Our data although limited by small sample size, shows that there is an estimated 42% reduction (p < 0.0001) in the rate of seizures. The MCT oil supplementation was well tolerated by most subjects except for minor GI side effects like nausea and loose stools. Most subjects developed ketones in their urine at some point during the trial.
MCT oil supplementation reduced seizure frequency in study participants. The reported side effects included mild nausea, stomachache, loose stools. A placebo-controlled study will be more informative. |
---|---|
AbstractList | We set out to determine whether adding medium chain triglyceride (MCT) oil as a dietary supplement to standard diet in adult subjects with intractable epilepsy in a U.S. neurology clinical practice was associated with a reduction in number of seizures. We secondarily aimed to determine whether subjects experienced any side effects and whether there was a presence of urinary ketones while using MCT oil as a dietary supplement.OBJECTIVEWe set out to determine whether adding medium chain triglyceride (MCT) oil as a dietary supplement to standard diet in adult subjects with intractable epilepsy in a U.S. neurology clinical practice was associated with a reduction in number of seizures. We secondarily aimed to determine whether subjects experienced any side effects and whether there was a presence of urinary ketones while using MCT oil as a dietary supplement.Adult patients with intractable epilepsy were recruited at standard of care clinical visits with their epileptologist. Once enrolled, subjects were instructed to supplement their diet with MCT oil as tolerated twice daily for three months (including a 1-2 week titration period, followed by a 1-2 week tapering off window) while keeping a seizure diary to record total number of seizures, presence of urinary ketones, and any side effects.METHODSAdult patients with intractable epilepsy were recruited at standard of care clinical visits with their epileptologist. Once enrolled, subjects were instructed to supplement their diet with MCT oil as tolerated twice daily for three months (including a 1-2 week titration period, followed by a 1-2 week tapering off window) while keeping a seizure diary to record total number of seizures, presence of urinary ketones, and any side effects.Our data although limited by small sample size, shows that there is an estimated 42% reduction (p < 0.0001) in the rate of seizures. The MCT oil supplementation was well tolerated by most subjects except for minor GI side effects like nausea and loose stools. Most subjects developed ketones in their urine at some point during the trial.RESULTSOur data although limited by small sample size, shows that there is an estimated 42% reduction (p < 0.0001) in the rate of seizures. The MCT oil supplementation was well tolerated by most subjects except for minor GI side effects like nausea and loose stools. Most subjects developed ketones in their urine at some point during the trial.MCT oil supplementation reduced seizure frequency in study participants. The reported side effects included mild nausea, stomachache, loose stools. A placebo-controlled study will be more informative.CONCLUSIONSMCT oil supplementation reduced seizure frequency in study participants. The reported side effects included mild nausea, stomachache, loose stools. A placebo-controlled study will be more informative. We set out to determine whether adding medium chain triglyceride (MCT) oil as a dietary supplement to standard diet in adult subjects with intractable epilepsy in a U.S. neurology clinical practice was associated with a reduction in number of seizures. We secondarily aimed to determine whether subjects experienced any side effects and whether there was a presence of urinary ketones while using MCT oil as a dietary supplement. Adult patients with intractable epilepsy were recruited at standard of care clinical visits with their epileptologist. Once enrolled, subjects were instructed to supplement their diet with MCT oil as tolerated twice daily for three months (including a 1-2 week titration period, followed by a 1-2 week tapering off window) while keeping a seizure diary to record total number of seizures, presence of urinary ketones, and any side effects. Our data although limited by small sample size, shows that there is an estimated 42% reduction (p < 0.0001) in the rate of seizures. The MCT oil supplementation was well tolerated by most subjects except for minor GI side effects like nausea and loose stools. Most subjects developed ketones in their urine at some point during the trial. MCT oil supplementation reduced seizure frequency in study participants. The reported side effects included mild nausea, stomachache, loose stools. A placebo-controlled study will be more informative. We set out to determine whether adding medium chain triglyceride (MCT) oil as a dietary supplement to standard diet in adult subjects with intractable epilepsy in a U.S. neurology clinical practice was associated with a reduction in number of seizures. We secondarily aimed to determine whether subjects experienced any side effects and whether there was a presence of urinary ketones while using MCT oil as a dietary supplement. Adult patients with intractable epilepsy were recruited at standard of care clinical visits with their epileptologist. Once enrolled, subjects were instructed to supplement their diet with MCT oil as tolerated twice daily for three months (including a 1-2 week titration period, followed by a 1-2 week tapering off window) while keeping a seizure diary to record total number of seizures, presence of urinary ketones, and any side effects. Our data although limited by small sample size, shows that there is an estimated 42% reduction ( < 0.0001) in the rate of seizures. The MCT oil supplementation was well tolerated by most subjects except for minor GI side effects like nausea and loose stools. Most subjects developed ketones in their urine at some point during the trial. MCT oil supplementation reduced seizure frequency in study participants. The reported side effects included mild nausea, stomachache, loose stools. A placebo-controlled study will be more informative. |
Author | Rasmussen, Emmaline Tideman, Samuel Frech, Robert Patel, Vimal Frigerio, Roberta Narayanan, Jaishree |
Author_xml | – sequence: 1 givenname: Emmaline surname: Rasmussen fullname: Rasmussen, Emmaline organization: NorthShore University HealthSystem – sequence: 2 givenname: Vimal surname: Patel fullname: Patel, Vimal organization: NorthShore University HealthSystem – sequence: 3 givenname: Samuel surname: Tideman fullname: Tideman, Samuel organization: NorthShore University HealthSystem – sequence: 4 givenname: Robert surname: Frech fullname: Frech, Robert organization: NorthShore University HealthSystem – sequence: 5 givenname: Roberta surname: Frigerio fullname: Frigerio, Roberta organization: NorthShore University HealthSystem – sequence: 6 givenname: Jaishree surname: Narayanan fullname: Narayanan, Jaishree email: kgulukota@yahoo.com organization: NorthShore University HealthSystem |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35470782$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkTtvFDEUhS0URB7wE0AuaSb4MfbMiga0CiRSEM0WdJbXvo6MPPZge4QmDX8dr3ZDQQHNvVdX3znFOZfoLKYICL2m5JqSkbyjhI09Fd-uGWGsDSlGKp-hC9oPshs5EWftbkx3gM7RZSnfCWFUjPIFOueiH8gwsgv068Y5b7RZcXK4LPMcYIJYdcBftjucfMAp4gL-ccmAM9jFVN8-DdZ2CRXbvDx0GYovVceKYfYB5rLiDmtcfHwI0JnmBxmnGWIX9B4CblCquNTFri_Rc6dDgVenfYV2n25229vu_uvnu-3H-85wKWtnNRl13wN3jEpLrRbc2d6ZDTEA-15srBPWWk6lJntjNhQIMMf70Q6Gj4xfobdH2zmnHwuUqiZfDISgI6SlKCaFEJLKfmjomxO67Cewas5-0nlVT5k1QBwBk1MpGdwfhBJ16EY9daMO3ahTN033_i-d8VUf4qxZ-_Bf9Yej2keX8qR_physqnoNKbuso_FF8X9b_Aaoxqn5 |
CitedBy_id | crossref_primary_10_1111_apha_14104 crossref_primary_10_1152_ajpcell_00241_2024 crossref_primary_10_1002_jbt_70213 crossref_primary_10_1007_s11101_024_09969_1 crossref_primary_10_1016_j_hnm_2024_200250 crossref_primary_10_3390_ijms25189869 crossref_primary_10_3390_nu14235003 |
Cites_doi | 10.1002/epi4.12225 10.1111/j.1528-1167.2008.01821.x 10.1080/1028415X.2019.1627769 10.1016/j.eplepsyres.2012.06.007 10.1016/j.cell.2018.06.051 10.1097/01.nrl.0000160818.58821.d2 10.1111/j.1528-1167.2009.02397.x 10.1155/2013/809151 10.1016/j.eplepsyres.2011.04.009 10.1016/j.pediatrneurol.2006.01.005 10.1212/01.wnl.0000142991.14507.b5 10.1002/14651858 10.3390/nu12092645 10.1016/s0140-6736(98)05114-9 10.1111/j.1528-1167.2008.01870.x 10.1016/j.brainresrev.2008.09.002 10.1093/brain/awv325 10.1016/S1474-4422(08)70092-9 10.1007/s12519-017-0053-2 10.17265/2159-5313/2016.09.003 10.1212/wnl.21.11.1097 10.2147/JEP.S267029 10.1016/S1474-4422(17)30408-8 10.1016/j.neuropharm.2011.12.015 10.1111/j.1528-1167.2007.00915.x |
ContentType | Journal Article |
Copyright | 2022 Informa UK Limited, trading as Taylor & Francis Group 2022 |
Copyright_xml | – notice: 2022 Informa UK Limited, trading as Taylor & Francis Group 2022 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1080/1028415X.2022.2065816 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Diet & Clinical Nutrition |
EISSN | 1476-8305 |
EndPage | 539 |
ExternalDocumentID | 35470782 10_1080_1028415X_2022_2065816 2065816 |
Genre | Research Article Clinical Trial Journal Article |
GrantInformation_xml | – fundername: NOW Foods |
GroupedDBID | --- 002 0BK 0R~ 123 1~B 29N 2QV 36B 4.4 53G A8Z AALUX AAMIU AAPUL AAQRR ABBKH ABDBF ABEIZ ABIVO ABLCE ABLIJ ABUPF ABXYU ACENM ACGEJ ACGFS ACIEZ ACKLR ACUHS ACVOX ADCVX ADXPE AECIN AENEX AGDLA AGFJD AGRBW AGYJP AIJEM AIRBT AJWEG AKBVH ALMA_UNASSIGNED_HOLDINGS ALQZU ALYBC ARJSQ BLEHA BOHLJ CCCUG CS3 DXH E01 EAP EBC EBD EBS EMB EMK EMOBN EPL ESTFP ESX F5P H13 HCLVR HZ~ KYCEM LJTGL M4Z MV1 O9- P2P P76 P7B RNANH RVRKI SV3 TBQAZ TERGH TFL TFW TUROJ TUS AAGDL AAYXX ABWVI ADYSH AFRVT AMPGV CITATION 5VS ABGNL ACWGZ ADVEQ AEIQB AEXKJ AFLJA AGXXK APIUT AWYRJ CAG CGR COF COGVJ CUY CVF ECM EIF EJD M46 NPM 7X8 TASJS |
ID | FETCH-LOGICAL-c366t-da08a44e3f216d1da53fd4fc90ceeb459df5ddd316a0bcc91e0e2f348d7c3823 |
ISSN | 1028-415X 1476-8305 |
IngestDate | Tue Aug 05 10:57:26 EDT 2025 Wed Feb 19 02:23:40 EST 2025 Thu Apr 24 22:59:45 EDT 2025 Tue Jul 01 00:40:23 EDT 2025 Wed Dec 25 09:04:38 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | ketosis Drug resistant epilepsy dietary supplements seizures standard of care intractable epilepsy ketones medium chain triglycerides |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c366t-da08a44e3f216d1da53fd4fc90ceeb459df5ddd316a0bcc91e0e2f348d7c3823 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
PMID | 35470782 |
PQID | 2655561647 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | informaworld_taylorfrancis_310_1080_1028415X_2022_2065816 pubmed_primary_35470782 crossref_primary_10_1080_1028415X_2022_2065816 crossref_citationtrail_10_1080_1028415X_2022_2065816 proquest_miscellaneous_2655561647 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-06-03 |
PublicationDateYYYYMMDD | 2023-06-03 |
PublicationDate_xml | – month: 06 year: 2023 text: 2023-06-03 day: 03 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Nutritional neuroscience |
PublicationTitleAlternate | Nutr Neurosci |
PublicationYear | 2023 |
Publisher | Taylor & Francis |
Publisher_xml | – name: Taylor & Francis |
References | Wilder RM. (CIT0017) 1921; 2 CIT0010 CIT0012 Geyelin HR. (CIT0006) 1921; 99 CIT0011 CIT0014 CIT0013 CIT0016 CIT0015 CIT0018 CIT0019 CIT0021 CIT0020 CIT0001 CIT0023 CIT0022 Guelpa G (CIT0005) 1911; 78 CIT0003 CIT0025 CIT0002 CIT0024 CIT0027 CIT0004 CIT0026 CIT0007 CIT0028 CIT0009 CIT0008 |
References_xml | – ident: CIT0007 doi: 10.1002/epi4.12225 – ident: CIT0018 doi: 10.1111/j.1528-1167.2008.01821.x – ident: CIT0024 doi: 10.1080/1028415X.2019.1627769 – ident: CIT0009 doi: 10.1016/j.eplepsyres.2012.06.007 – ident: CIT0027 doi: 10.1016/j.cell.2018.06.051 – ident: CIT0015 doi: 10.1097/01.nrl.0000160818.58821.d2 – ident: CIT0002 doi: 10.1111/j.1528-1167.2009.02397.x – ident: CIT0016 doi: 10.1155/2013/809151 – ident: CIT0011 doi: 10.1016/j.eplepsyres.2011.04.009 – ident: CIT0010 doi: 10.1016/j.pediatrneurol.2006.01.005 – ident: CIT0003 doi: 10.1212/01.wnl.0000142991.14507.b5 – ident: CIT0014 doi: 10.1002/14651858 – ident: CIT0023 doi: 10.3390/nu12092645 – volume: 2 start-page: 307 year: 1921 ident: CIT0017 publication-title: The Clinic Bulletin – ident: CIT0004 doi: 10.1016/s0140-6736(98)05114-9 – ident: CIT0012 doi: 10.1111/j.1528-1167.2008.01870.x – ident: CIT0026 doi: 10.1016/j.brainresrev.2008.09.002 – volume: 99 start-page: 1037 year: 1921 ident: CIT0006 publication-title: Med Rec – ident: CIT0022 doi: 10.1093/brain/awv325 – ident: CIT0013 doi: 10.1016/S1474-4422(08)70092-9 – ident: CIT0028 doi: 10.1007/s12519-017-0053-2 – ident: CIT0001 doi: 10.17265/2159-5313/2016.09.003 – ident: CIT0020 doi: 10.1212/wnl.21.11.1097 – ident: CIT0008 doi: 10.2147/JEP.S267029 – ident: CIT0019 doi: 10.1016/S1474-4422(17)30408-8 – ident: CIT0021 doi: 10.1016/j.neuropharm.2011.12.015 – volume: 78 start-page: 8 year: 1911 ident: CIT0005 publication-title: Revue de Thérapie Médico-Chirurgicale – ident: CIT0025 doi: 10.1111/j.1528-1167.2007.00915.x |
SSID | ssj0021586 |
Score | 2.3784854 |
Snippet | We set out to determine whether adding medium chain triglyceride (MCT) oil as a dietary supplement to standard diet in adult subjects with intractable epilepsy... |
SourceID | proquest pubmed crossref informaworld |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 535 |
SubjectTerms | Adult Diet, Ketogenic - adverse effects dietary supplements Drug resistant epilepsy Drug Resistant Epilepsy - drug therapy Humans intractable epilepsy Ketones ketosis medium chain triglycerides Pilot Projects seizures Seizures - drug therapy Seizures - prevention & control standard of care Triglycerides |
Title | Efficacy of supplemental MCT oil on seizure reduction of adult drug-resistant epilepsy - a single-center open-label pilot study |
URI | https://www.tandfonline.com/doi/abs/10.1080/1028415X.2022.2065816 https://www.ncbi.nlm.nih.gov/pubmed/35470782 https://www.proquest.com/docview/2655561647 |
Volume | 26 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NjtMwELbK7oUL4p-ygIyEuEQpSeyk6XH_qhXSIoQK6i1yYhuK0qRqksPuCZ6BZ-JFeBJmEidNobAsl6hyY8fNfB2PxzPfEPIiwcObINa21F5gczce23GopS1hsY29hAGo0KF__iY4e89fz_35YPC9F7VUlfEoudyZV_I_UoU2kCtmyV5Dst2g0ACfQb5wBQnD9Z9kfIr8D1ivHSy-AstzKkPVf348s_JFiicBhVpc4iHBGjlaW_OwZt2w5Lr6aMN2G03IrLTUCjTEqriw2gAIZgkLXQmpsjGGU60trLVlA25UasHNedljp_3c5vEadn-YRY8rs4PPO1Esq6J1-yyXIu0d7L8Fw7d2SX9YLMUm9ANr2Bo_rVhWqvtiCtr60yY8vO_A8FgdaMV6Ord28Ln-vFmSmjY-DuyQOX5fUTep9QaQfa3rN4wnZgH3G3ak39aGJpgSn4YPG8FUMBEPLDB3Bxf3L2tkF7noGkrVdpgIh4nMMDfIvge7FVC3-4dHJ0fTbufv-nXJ0e6XtqlkofNq53y2jKQtCt0_b4Rqg2h2m9wyOxl62MDyDhmo7C4ZnixUSV9SQzeb0g4P98jXFq4017QPVwpwpQBXmmfUwJV2cMWba7jSbbjSFq70x5dvVNAtoNINUGkNVFoD9T6ZTU9nx2e2qQBiJywISlsKJxScK6Y9N5CuFD7Tkutk4oBtF3N_IrUvpWRuIJw4SSaucpSnGQ_lOMED7gdkL8sz9YjQ0GFcO45g8djlkkmRuPDaFVdqoqUInCHh7RuPEsOOj0Va0uivEh-SUddt1dDDXNVh0hdnVNZ-Od0U0YnYFX2ft7KPYBHAkz2RqbwqIi_wscxtwMdD8rABRTcd5vOaFfPxdad6QG5u_q5PyF65rtRTsMDL-JnB909ZPtc- |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Efficacy+of+supplemental+MCT+oil+on+seizure+reduction+of+adult+drug-resistant+epilepsy+%E2%80%93+a+single-center+open-label+pilot+study&rft.jtitle=Nutritional+neuroscience&rft.au=Rasmussen%2C+Emmaline&rft.au=Patel%2C+Vimal&rft.au=Tideman%2C+Samuel&rft.au=Frech%2C+Robert&rft.date=2023-06-03&rft.issn=1028-415X&rft.eissn=1476-8305&rft.volume=26&rft.issue=6&rft.spage=535&rft.epage=539&rft_id=info:doi/10.1080%2F1028415X.2022.2065816&rft.externalDBID=n%2Fa&rft.externalDocID=10_1080_1028415X_2022_2065816 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1028-415X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1028-415X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1028-415X&client=summon |